PeptideGuider.com |

Quick Answer A peptide certificate of analysis (COA) is a laboratory report documenting a compound’s identity and purity, normally through […]

Sermorelin: A Former FDA Drug, Now a Compounded Peptide

Quick Answer Sermorelin is a growth hormone-releasing hormone (GHRH) analogue that was an FDA-approved drug, sold as Geref, before its

Quick Answer CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) that prompts the pituitary to release growth hormone

Quick Answer Ipamorelin is a synthetic pentapeptide that triggers the body to release its own growth hormone (GH) by activating

Quick Answer Retatrutide is Eli Lilly’s investigational “triple agonist” that activates the GIP, GLP-1, and glucagon receptors at once, and

Quick Answer Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist sold as Mounjaro (type 2 diabetes) and Zepbound (weight management

Quick Answer Semaglutide is an FDA-approved GLP-1 receptor agonist sold as Ozempic (type 2 diabetes), Wegovy (weight management and cardiovascular

Quick Answer TB-500 is a synthetic peptide fragment of thymosin beta-4, a naturally occurring 43-amino-acid protein involved in cell migration,

Quick Answer BPC-157 is a synthetic 15-amino-acid peptide derived from human gastric juice, studied extensively in preclinical models for tissue

Quick Answer Most research peptides in Australia are classified as Schedule 4 (prescription-only) or higher under the TGA’s Poisons Standard,